Page 11 - AN-1-3
P. 11

Advanced Neurology                                         Long-term in vivo MRI tracking of SPIO-labeled NSCs




                         A                                   B














                         C                                   D













                         E
                                                                        F












            Figure 1. Characterization of SPIO-labeled neural stem cells (NSCs). (A–D) NSCs were incubated with SPIO at six different concentrations. (A) Cell
            viability of NSCs treated with SPIO at various concentrations. Cell viability was measured by CCK-8 assay at 48 h after SPIO treatment. n = 3 independent
            experiments/group. (B) PB staining of NSCs treated with SPIO at different concentrations. NSCs were stained with PB iron at 48 h after SPIO treatment.
            Scale bar = 100 μm. (C) T2-weighted MRI analysis of NSCs at 48 h after SPIO treatment at different concentrations. (D) Total amounts of iron in NSCs
            treated with different concentrations of SPIOs for 48 h measured by ICP-MS. (E and F) BrdU labeling analysis of SPIO-labeled NSCs. (E) Representative
            images. Scale bar = 100 μm. (F) Quantitative analysis. All data are presented as mean ± SEM of three independent experiments. *P < 0.05, **P < 0.01, and
            ***P < 0.001 versus the control group.
            BrdU: Bromodeoxyuridine: ICP-MS: Inductively coupled plasma mass spectrometer, MRI: Magnetic resonance imaging, NSCs: Neural stem cells, PB:
            Prussian blue, SEM: Standard error of the mean, SPIO: Superparamagnetic iron oxide.

            On the other hand, PB staining can also be used for   are carried by NSCs, we examined the correlation
            tracking  transplanted  NSCs  in  tMCAO  mice.  As  shown   between transplanted NSCs and SPIO nanoparticles. The
            in Figure 3C, SPIO-labeled NSCs were identified over the   synthesis of SPIO nanoparticles labeled with rhodamine
            injection site and infarcted area at 28 days after tMCAO.   B (RhB) has been described in previous research . As
                                                                                                        [25]
            These results suggest that SPIO labeling allows  in vivo   shown in Figure 4A, the GFP NSCs labeling rate (green)
                                                                                       +
            tracking of transplanted NSCs with MRI. The results also   was  colocalized with RhB-labeled  SPIO (red)  in vitro.
            confirmed the migration of transplanted NSCs from the   Microinjection of SPIO-RhB-labeled GFP  NSCs was then
                                                                                                +
            injection site to the infarcted area in tMCAO mouse brain.  performed in tMCAO mice. At 28 days after tMCAO, a
                                                               fluorescence signal was detected in the peri-infarct area
            3.4. Transplanted neural stem cells labeled with   of  the  cortex  in  the ischemic  hemisphere  (Figure  4B).
            SPIO in tMCAO mice                                 This result demonstrated that the SPIO-labeled NSCs had
            To confirm whether the signals of SPIO nanoparticles   migrated to the ischemic area. The above experiments not
            detected  by  MRI  and  PB  staining  in  the  ischemic  area   only confirmed that the transplanted NSCs labeled with


            Volume 1 Issue 3 (2022)                         5                       https://doi.org/10.36922/an.v1i3.278
   6   7   8   9   10   11   12   13   14   15   16